CAZZATO, MASSIMILIANO
 Distribuzione geografica
Continente #
EU - Europa 246
NA - Nord America 207
AS - Asia 76
AF - Africa 33
OC - Oceania 1
SA - Sud America 1
Totale 564
Nazione #
US - Stati Uniti d'America 204
IT - Italia 94
SE - Svezia 68
SG - Singapore 31
IN - India 24
DE - Germania 20
GB - Regno Unito 19
CI - Costa d'Avorio 18
BG - Bulgaria 17
SN - Senegal 8
FR - Francia 7
NG - Nigeria 7
FI - Finlandia 6
HK - Hong Kong 6
ID - Indonesia 5
CN - Cina 4
CZ - Repubblica Ceca 3
JP - Giappone 3
PL - Polonia 3
CA - Canada 2
CH - Svizzera 2
ES - Italia 2
VN - Vietnam 2
AU - Australia 1
BR - Brasile 1
EE - Estonia 1
IE - Irlanda 1
LV - Lettonia 1
MX - Messico 1
SI - Slovenia 1
TH - Thailandia 1
UA - Ucraina 1
Totale 564
Città #
Chandler 27
Ashburn 25
Serra 23
Florence 20
Abidjan 18
Singapore 17
Sofia 17
London 15
Boardman 14
New York 13
Fairfield 11
Redwood City 11
Dakar 8
Princeton 8
Lagos 7
Lawrence 7
Marseille 7
Pisa 7
Dallas 6
Helsinki 6
Hong Kong 6
Hyderabad 6
Medford 6
Rome 6
Jakarta 5
Milan 5
Wilmington 5
Duncan 4
Kent 4
Scarlino 4
Washington 4
Bremen 3
Cesano Boscone 3
Esslingen am Neckar 3
Houston 3
Mumbai 3
Munich 3
Ogden 3
Redmond 3
Warsaw 3
Ann Arbor 2
Bengaluru 2
Brno 2
Chicago 2
Fiesole 2
Füllinsdorf 2
Livorno 2
Madrid 2
Naples 2
San Diego 2
Toronto 2
Bacoli 1
Belfast 1
Bhubaneswar 1
Cambridge 1
Cogorno 1
Dublin 1
Frascati 1
Kolkata 1
Ljubljana 1
Lucca 1
Monza 1
Norwalk 1
Olomouc 1
Padova 1
Pontotoc 1
Porto Azzurro 1
Tacoma 1
Tallinn 1
Tokyo 1
Totale 390
Nome #
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 86
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 82
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 80
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 66
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 56
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 55
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 54
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 52
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 18
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 14
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 13
Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort. 9
Totale 585
Categoria #
all - tutte 2.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 1 3 0 7 3 5 0 2 12
2021/2022169 6 5 21 36 25 15 9 6 7 4 11 24
2022/2023180 24 38 16 5 13 13 10 2 40 0 19 0
2023/2024152 0 9 14 2 12 26 21 18 1 0 20 29
2024/202551 7 19 25 0 0 0 0 0 0 0 0 0
Totale 585